Area of research
Cardiology and Cardiovascular Medicine · Oncology
Research interest
Research interests include Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Viral Infections and Immunology Research, and Chemotherapy-induced cardiotoxicity and mitigation.
Immune checkpoint inhibitor-associated myocarditis: a novel risk score
Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool
Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction
Heart Failure with Preserved Ejection Fraction in Cancer Patients and Survivors. A Scientific Statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology
Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America
Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study
SGLT2i and Primary Prevention of Cancer Therapy–Related Cardiac Dysfunction in Patients With Diabetes
GLP-1 Receptor Agonist in Nonobese Patients with Type 2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction
Cardio-Oncology and Heart Failure: AL Amyloidosis for the Heart Failure Clinician: a Supplement to the Scientific Statement from the Heart Failure Society of America
Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis
SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy–Related Cardiac Dysfunction
The Multidisciplinary Heart Team in Cardiovascular Medicine
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
An ERK5-NRF2 Axis Mediates Senescence-Associated Stemness and Atherosclerosis
Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative
Advances in Multimodality Imaging in Cardio-Oncology
Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor–Associated Myocarditis
Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization
Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee
Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?
N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity
Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study
Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone
Gender Disparities in Evidence-Based Statin Therapy in Patients With Cardiovascular Disease
Pre-Morbid Body Mass Index and Mortality After Incident Heart Failure